Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc. (USPH)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2010
Business Overview: USPH operates outpatient physical therapy clinics providing pre- and post-operative care, sports injury treatment, and rehabilitation. As of December 31, 2010, the company operated 392 clinics in 42 states. The business model primarily utilizes "Clinic Partnerships" where the company holds a majority interest (typically 64% limited partnership interest) and managing therapists hold the remainder. The company also operates wholly-owned facilities and manages third-party practices.
Key Financial Metrics
| Metric | 2010 | 2009 | Change |
|---|---|---|---|
| Net Revenues | $211.2 million | $201.4 million | +4.9% |
| Net Income (Common Shareholders) | $15.6 million | $11.8 million | +33.0% |
| Diluted EPS | $1.32 | $1.00 | +32.0% |
| Operating Income | $33.2 million | $28.3 million | +17.5% |
| Cash and Cash Equivalents | $9.2 million | $6.4 million | +43.8% |
| Working Capital | $25.1 million | $18.3 million | +37.2% |
| Long-Term Debt | $5.8 million | $0.4 million | Significant Increase |
| Current Ratio | 2.76 | 2.24 | Improvement |
Operational Metrics: Total patient visits increased 1.5% to 1.93 million. Net patient revenue per visit rose 3.0% to $105.92. Clinic operating costs represented 73.5% of net revenues in 2010, down from 74.3% in 2009.
Material Changes vs. Prior Period
- Acquisitions: The company acquired 25 clinics in 2010 through three major transactions (Northeast, Mid-Atlantic, and Southeast acquisitions), compared to no clinic acquisitions in 2009. This drove a significant increase in goodwill from $57.2 million to $79.4 million.
- Revenue Growth: Driven by a 3.0% increase in revenue per visit and a 1.5% increase in total visits. New clinics contributed 62,000 additional visits, partially offset by a decrease in visits at mature clinics.
- Profitability: Net income attributable to common shareholders grew 33.0%, outpacing revenue growth due to improved operating margins and lower corporate office costs (down $0.7 million).
- Debt Structure: Long-term debt increased significantly due to the utilization of the revolving credit facility ($5.5 million outstanding) and seller notes ($0.5 million) to fund acquisitions. In 2009, long-term debt was minimal ($0.4 million).
- Dividend Initiation: In March 2011 (subsequent to year-end), the company announced its first quarterly dividend of $0.08 per share.
Guidance, Outlook, Risks, and Contingencies
Outlook and Strategy: Management intends to continue developing new clinics, opening satellite locations, and evaluating acquisition opportunities. The company plans to increase patient volume through marketing and new programs.
Key Risks:
- Reimbursement Environment: The company is heavily dependent on third-party payors (77% private/commercial, 23% Medicare/Medicaid). A 2011 CMS ruling on Multiple Procedure Payment Reduction (MPPR) is estimated to reduce Medicare reimbursement rates by 5% to 7%.
- Regulatory Compliance: Operations are subject to extensive federal and state regulations, including the Stark Law, Fraud and Abuse Law, and HIPAA. Non-compliance could result in penalties or exclusion from government programs.
- Medicare Cap: The annual Medicare therapy cap ($1,870 for 2011) may result in lost revenues if exceptions are not granted for medically necessary services.
- Goodwill Impairment: With significant goodwill on the balance sheet ($79.4 million), future market deterioration or underperformance of acquired clinics could trigger impairment charges.
Contingencies: The company has contingent consideration obligations related to the 2008 Mid-Atlantic Acquisition (up to $1.5 million) and the 2008 RMG acquisition (up to $3.8 million) based on future operating results.
Investor Verification Checklist
- Medicare Rate Impact: Verify the actual financial impact of the 2011 MPPR rate reduction on Medicare revenue, which constitutes ~23% of total revenue.
- Acquisition Integration: Monitor the performance of the 25 clinics acquired in late 2010 to ensure they meet projected revenue and profitability targets.
- Debt Covenants: Confirm continued compliance with the revolving credit facility covenants, specifically the consolidated leverage ratio (must be < 1.0 to 1.0 for stock repurchases) and fixed charge coverage ratio.
- Goodwill Valuation: Review the annual goodwill impairment testing results, particularly for the 11 reporting units that account for 92% of total goodwill.
- Noncontrolling Interest Distributions: Track cash outflows for distributions to noncontrolling interests (therapist partners), which totaled $9.6 million in 2010.